Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-07

Clinical Trial Update: Aquaporin-4 Single Nucleotide Polymorphisms in Patients With Idiopathic and Familial Parkinson's Disease

View source ↗

Summary

University of Exeter is studying aquaporin-4 single nucleotide polymorphisms in people with idiopathic and familial Parkinson disease; the trial status is ACTIV…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Exeter | Conditions: Parkinson Disease | Status: ACTIVE_NOT_RECRUITING